...
首页> 外文期刊>European radiology >Percutaneous treatment of liver tumors with an adapted probe for cooled-tip, impedance-controlled radio-frequency ablation under open-magnet MR guidance: initial results.
【24h】

Percutaneous treatment of liver tumors with an adapted probe for cooled-tip, impedance-controlled radio-frequency ablation under open-magnet MR guidance: initial results.

机译:在开放磁铁MR引导下,用适合于冷却尖端,阻抗控制的射频消融的探头对皮肤肿瘤进行经皮治疗:初步结果。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Percutaneous radio-frequency (RF) ablation of liver tumors is usually performed under guidance of real-time US, but some tumor nodules in some patients cannot be adequately visualized with this technique. We report our preliminary results with an MR-compatible, internally perfused 17-G RF probe adapted to a standard RF generator for impedance-controlled RF ablation under MR guidance. Following initial testing of the probe for MR compatibility, artifacts and macroscopic effects on an ex vivo pig liver, four patients with eight neoplastic liver nodules (five metastatic and three primary), which could not be properly targeted by US, were treated with the cooled-tip technique under MRI guidance in an open 0.23-T magnet. Metallic artifacts produced by the probe were useful for accurate placement and did not interfere with MRI monitoring at the end of the procedure. Based on imaging findings, the immediate result of RF was considered adequate in all instances. Local recurrence occurred in one instance after 6 months, requiring repeat treatment. No adverse effects were noted. Initial experience suggests that the probe we used allows to perform impedance-controlled cooled-tip RF ablation of liver tumors under open-magnet MR guidance.
机译:肝肿瘤的经皮射频消融术通常在实时超声引导下进行,但是某些患者的某些肿瘤结节无法通过这种技术充分观察到。我们使用与MR兼容的内部灌流17-G RF探头报告了我们的初步结果,该探头适用于标准RF发生器,用于在MR指导下进行阻抗控制的RF消融。在对探头的MR兼容性,伪影和对离体猪肝脏的宏观影响进行了初步测试后,用冷却液治疗了4例8个肿瘤肝结节(5个转移灶和3个原发灶)的患者,这些患者不能被US正确靶向, MRI技术在开放的0.23-T磁体中进行尖端技术。探针产生的金属伪影可用于准确放置,并且在操作结束时不会干扰MRI监测。根据影像学发现,RF的即时结果在所有情况下都被认为是足够的。 6个月后有1例发生局部复发,需要再次治疗。没有发现不良反应。最初的经验表明,我们使用的探针允许在开放式MR引导下对肝脏肿瘤进行阻抗控制的冷端RF消融。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号